St. David's Office of Research

Main Navigation



St. David’s Medical Center Enrolls in Two COVID-19 Studies

AUSTIN, Texas—St. David’s Medical Center is testing two promising COVID-19 therapies in clinical trials. The medications being tested are lenzilumab and ruxolitinib, both of which focus on inflammatory pathways in…

St. David’s NICU Enrolls in Probiotics Study

AUSTIN, Texas—St. David’s Medical Center Neonatal Intensive Care Unit (NICU) is participating in a clinical trial on necrotizing enterocolitis (NEC).  NEC is a severe inflammatory disease of the gastrointestinal systems…

St. David’s HealthCare Advances COVID-19 Clinical Research

AUSTIN, Texas—St. David’s HealthCare through the Office of Research is participating in multiple Phase III clinical trials on COVID-19, particularly those studying treatments on patients with severe to life threatening…